Complement and non-complement activating functions of C1q: A prototypical innate immune molecule

Innate Immunity

Volumn 18, Issue 2, 2012, Pages 350-363

  Nayak, Annapurna ^a,b   Pednekar, Lina ^a,c   Reid, Kenneth B M ^d   Kishore, Uday ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b Jawaharlal Nehru Institute for Advanced Study   (India)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

C1q; C1q family; C1q receptors; complement dependent functions; complement independent functions

Indexed keywords

COMPLEMENT COMPONENT C1Q; LECTIN;

COMPLEMENT ACTIVATION; HUMAN; INNATE IMMUNITY; LIGAND BINDING; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN CONFORMATION; PROTEIN FUNCTION; REVIEW;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; HUMANS; IMMUNITY, INNATE; MEMBRANE GLYCOPROTEINS; RECEPTORS, COMPLEMENT;

EID: 84858387853     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425910396252     Document Type: Review

References (136)

1. Sellar GC, Blake DJ, Reid KB. Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q. Biochem J. 1991 ; 274: 481-490
2. Reid KB, Porter RR. Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J. 1976 ; 155: 19-23
3. Kishore U, Reid KB. C1q: structure, function, and receptors. Immunopharmacology. 2000 ; 49: 159-170 (Pubitemid 30445227)
4. Kishore U, Reid KB. Modular organization of proteins containing C1q-like globular domain. Immunopharmacology. 1999 ; 42: 15-21 (Pubitemid 29322283)
5. Kishore U, Gupta SK, Perdikoulis MV, Kojouharova MS, Urban BC, Reid KB. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J Immunol. 2003 ; 171: 812-820 (Pubitemid 36871392)
6. Kishore U, Ghai R, Greenhough TJ, et al. Structural and functional anatomy of the globular domain of the complement protein C1q. Immunol Lett. 2004 ; 95: 113-128 (Pubitemid 39237657)
7. Kojouharova MS, Gadjeva MG, Tsacheva IG, et al. Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction. J Immunol. 2004 ; 172: 4351-4358 (Pubitemid 38375250)
8. Gadjeva MG, Rouseva MM, Zlatarova AS, Reid KB, Kishore U, Kojouharova MS. Interaction of human C1q with IgG and IgM: revisited. Biochemistry. 2008 ; 47: 13093-13102
9. Marqués G, Antón LC, Barrio E, et al. Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G. J Biol Chem. 1993 ; 268: 10393-10393
10. Duncan AR, Winter G. The binding site for C1q on IgG. Nature. 1988 ; 332: 738-740
11. Zlatarova AS, Rouseva M, Roumenina LT, et al. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q. Biochemistry. 2006 ; 45: 9979-9988 (Pubitemid 44257392)
12. Nauta AJ, Trouw LA, Daha MR, Tijsma O, Nieuwland R, Schwaeble WJ. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol. 2002 ; 32: 1726-1736 (Pubitemid 34679160)
13. Roos A, Xu W, Castellano G, et al. A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol. 2004 ; 34: 921-929 (Pubitemid 39255970)
14. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. J Immunol. 1997 ; 158: 4525-4528
15. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol. 2001 ; 166: 3231-3239 (Pubitemid 33117322)
16. Zwart B, Ciurana C, Rensink I, Manoe R, Hack CE, Aarden LA. Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells. Autoimmunity. 2004 ; 37: 95-102 (Pubitemid 38594273)
17. Roughley PJ, Lee ER. Cartilage proteoglycans: structure and potential functions. Microsc Res Tech. 1994 ; 28: 385-397 (Pubitemid 24222670)
18. Sjöberg AP, Manderson GA, Mörgelin M, Day AJ, Heinegård D, Blom AM. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol. 2009 ; 46: 830-839
19. Danesh J, Wheeler JG, Hirschfield GM, et al. C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350: 1387-1397 (Pubitemid 38419992)
20. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-Reactive protein and the risk of incident colorectal cancer. JAMA. 2004 ; 291: 585-590 (Pubitemid 38500312)
21. Torzewski J, Torzewski M, Bowyer DE, et al. C-Reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998 ; 18: 1386-1392 (Pubitemid 28421875)
22. Bíró A, Rovó Z, Papp D, et al. Studies on the interactions between C-reactive protein and complement proteins. Immunology. 2007 ; 121: 40-50 (Pubitemid 46537662)
23. McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol. 2006 ; 176: 2950-2957
24. Biró A, Thielens NM, Cervenák L, Prohászka Z, Füst G, Arlaud GJ. Modified low density lipoproteins differentially bind and activate the C1 complex of complement. Mol Immunol. 2007 ; 44: 1169-1177 (Pubitemid 44415975)
25. Biro A, Ling WL, Arlaud GJ. Complement protein C1q recognizes enzymatically modified low-density lipoprotein through unesterified fatty acids generated by cholesterol esterase. Biochemistry. 2010 ; 49: 2167-2176
26. Chao FF, Blanchette-Mackie EJ, Tertov VV, Skarlatos SI, Chen YJ, Kruth HS. Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. J Biol Chem. 1992 ; 267: 4992-4998
27. Yin W, Ghebrehiwet B, Weksler B, Peerschke EI. Classical pathway complement activation on human endothelial cells. Mol Immunol. 2007 ; 44: 2228-2234 (Pubitemid 46097113)
28. Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. J Thromb Haemost. 2006 ; 4: 2035-2042 (Pubitemid 44226786)
29. Peerschke EI, Yin W, Alpert DR, Roubey RA, Salmon JE, Ghebrehiwet B. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies. Lupus. 2009 ; 18: 530-538
30. Roumenina LT, Popov KT, Bureeva SV, et al. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide. Biochim Biophys Acta. 2008 ; 1784: 1271-1276
31. Bonaparte RS, Hair PS, Banthia D, Marshall DM, Cunnion KM, Krishna NK. Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway. J Virol. 2008 ; 82: 817-827
32. Hair PS, Gronemus JQ, Crawford KB, et al. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation. Mol Immunol. 2010 ; 47: 792-798
33. Oberkersch R, Attorresi AI, Calabrese GC. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy. Thromb Res. 2010 ; 125: 240-245
34. Nayak A, Ferluga J, Tsolaki AG, Kishore U. The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol Lett. 2010 ; 131: 139-150
35. Färber K, Cheung G, Mitchell D, et al. C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. J Neurosci Res. 2009 ; 87: 644-652
36. Fraser DA, Pisalyaput K, Tenner AJ. C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J Neurochem. 2010 ; 112: 733-743
37. Bonifati DM, Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol. 2007 ; 44: 999-1010 (Pubitemid 44414994)
38. Stevens B, Allen NJ, Vazquez LE, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007 ; 131: 1164-1178 (Pubitemid 350235022)
39. Csomor E, Bajtay Z, Sándor N, et al. Complement protein C1q induces maturation of human dendritic cells. Mol Immunol. 2007 ; 44: 3389-3397 (Pubitemid 46678195)
40. Castellano G, Woltman AM, Schlagwein N, et al. Immune modulation of human dendritic cells by complement. Eur J Immunol. 2007 ; 37: 2803-2811 (Pubitemid 47578300)
41. Chen A, Gaddipati S, Hong Y, Volkman DJ, Peerschke EI, Ghebrehiwet B. Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol. 1994 ; 153: 1430-1440 (Pubitemid 24251088)
42. van Montfoort N, de Jong JM, Schuurhuis DH, et al. A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes. J Immunol. 2007 ; 178: 7581-7586 (Pubitemid 46898027)
43. Young KR, Ambrus JL, Malbran A, Fauci AS, Tenner AJ. Complement subcomponent C1q stimulates Ig production by human B lymphocytes. J Immunol. 1991 ; 146: 3356-3364
44. Yurasov S, Wardemann H, Hammersen J, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med. 2005 ; 201: 703-711 (Pubitemid 40395116)
45. Krumdieck R, Höök M, Rosenberg LC, Volanakis JE. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol. 1992 ; 149: 3695-3701
46. Groeneveld TW, Oroszlán M, Owens RT, et al. Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J Immunol. 2005 ; 175: 4715-4723 (Pubitemid 41362013)
47. Bohnsack JF, Tenner AJ, Laurie GW, Kleinman HK, Martin GR, Brown EJ. The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane. Proc Natl Acad Sci USA. 1985 ; 82: 3824-3828 (Pubitemid 15246444)
48. Sorvillo J, Gigli I, Pearlstein E. Fibronectin binding to complement subcomponent C1q. Localization of their respective binding sites. Biochem J. 1985 ; 226: 207-215 (Pubitemid 15127927)
49. Fraser DA, Laust AK, Nelson EL, Tenner AJ. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J Immunol. 2009 ; 183: 6175-6185
50. Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001 ; 194: 781-796
51. Jiang H, Cooper B, Robey FA, Gewurz H. DNA binds and activates complement via residues 14-26 of the human C1q A chain. J Biol Chem. 1992 ; 267: 25597-25601
52. Ghebrehiwet B, Lim BL, Peerschke EI, Willis AC, Reid KB. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med. 1994 ; 179: 1809-1821
53. Malhotra R, Thiel S, Reid KB, Sim RB. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med. 1990 ; 172: 955-959 (Pubitemid 20301242)
54. Malhotra R. Collectin receptor (C1q receptor): structure and function. Behring Inst. Mitt. 1993 ; 93: 254-261
55. Peerschke EI, Reid KB, Ghebrehiwet B. Identification of a novel 33-kDa C1q-binding site on human blood platelets. J Immunol. 1994 ; 152: 5896-5901 (Pubitemid 24174171)
56. Peterson KL, Zhang W, Lu PD, Keilbaugh SA, Peerschke EI, Ghebrehiwet B. The C1q-Binding Cell Membrane Proteins cC1q-R and gC1q-R Are Released from Activated Cells: Subcellular Distribution and Immunochemical Characterization. Clin Immunol Immunopathol. 1997 ; 84: 17-26 (Pubitemid 27293540)
57. Dedio J, Jahnen-Dechent W, Bachmann M, Müller-Esterl W. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol. 1998 ; 160: 3534-3542 (Pubitemid 28164749)
58. Lim BL, Reid KB, Ghebrehiwet B, Peerschke EI, Leigh LA, Preissner KT. The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor. J Biol Chem. 1996 ; 271: 26739-26744 (Pubitemid 26359082)
59. Fausther-Bovendo H, Vieillard V, Sagan S, Bismuth G, Debré P. HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway. PLoS Pathog. 2010 ; 6: e1000975 - e1000975
60. Peerschke EI, Ghebrehiwet B. The contribution of gC1qR/p33 in infection and inflammation. Immunobiol. 2007 ; 212: 333-342 (Pubitemid 46825239)
61. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. By Binding SIRPα or Calreticulin/CD91, Lung Collectins Act as Dual Function Surveillance Molecules to Suppress or Enhance Inflammation. Cell. 2003 ; 115: 13-23 (Pubitemid 37255314)
62. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: One protein, one gene, many functions. Biochem J. 1999 ; 344: 281-292 (Pubitemid 30011581)
63. Gregory CD, Devitt A. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?. Immunology. 2004 ; 113: 1-14 (Pubitemid 39178838)
64. Vegh Z, Kew RR, Gruber BL, Ghebrehiwet B. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. Mol Immunol. 2006 ; 43: 1402-1407 (Pubitemid 43356379)
65. Guan E, Robinson SL, Goodman EB, Tenner AJ. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J Immunol. 1994 ; 152: 4005-4016
66. Fonseca MI, Carpenter PM, Park M, Palmarini G, Nelson EL, Tenner AJ. C1qR(P), a myeloid cell receptor in blood, is predominantly expressed on endothelial cells in human tissue. J Leukoc Biol. 2001 ; 70: 793-800 (Pubitemid 33127014)
67. Nepomuceno RR, Ruiz S, Park M, Tenner AJ. C1qRP is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity. J Immunol. 1999 ; 162: 3583-3589 (Pubitemid 29313611)
68. McGreal E, Gasque P. Structure-function studies of the receptors for complement C1q. Biochem Soc Trans. 2002 ; 30: 1010-1014 (Pubitemid 36002397)
69. Medof ME, Iida K, Mold C, Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med. 1982 ; 156: 1739-1754 (Pubitemid 13167418)
70. Cornacoff JB, Hebert LA, Smead WL, VanAman ME, Birmingham DJ, Waxman FJ. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest. 1983 ; 71: 236-247 (Pubitemid 13137488)
71. Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A. C1q and C4b Bind Simultaneously to CR1 and Additively Support Erythrocyte Adhesion. J Immunol. 1999 ; 163: 5056-5063 (Pubitemid 29501274)
72. Yaskanin DD, Waxman FJ. Expression of the CR1 Receptor on Human Leukemia Derived CD4+ T Cell Lines. Cell Immunol. 1995 ; 163: 139-147
73. Weis JJ, Tedder TF, Fearon DT. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A. 1984 ; 81: 881-885 (Pubitemid 14197605)
74. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med. 1980 ; 152: 20-30 (Pubitemid 10090511)
75. Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A. C1q and C4b Bind Simultaneously to CR1 and Additively Support Erythrocyte Adhesion. J Immunol. 1999 ; 163: 5056-5063 (Pubitemid 29501274)
76. Eggleton P, Tenner AJ, Reid KBM. C1q receptors. Clin Exp Immunol. 2000 ; 120: 406-412 (Pubitemid 30365543)
77. Duus K, Hansen EW, Tacnet P, Frachet P, Arlaud GJ, Thielens NM, et al. Direct interaction between CD91 and C1q. FEBS J. 2010 ; 277: 3526-3537
78. Kishore U, Gaboriaud C, Waters P, Shrive AK, Greenhough TJ, Reid KB, et al. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol. 2004 ; 25: 551-561 (Pubitemid 39208354)
79. Ghai R, Waters P, Roumenina LT, Gadjeva M, Kojouharova MS, Reid KB, et al. C1q and its growing family. Immunobiol. 2007 ; 212: 253-266 (Pubitemid 46830353)
80. Tom Tang Y, Hu T, Arterburn M, Boyle B, Bright JM, Palencia S, et al. The complete complement of C1q-domain-containing proteins in Homo sapiens. Genomics. 2005 ; 86: 100-111 (Pubitemid 40805340)
81. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes. 2002 ; 51: 2325-2328 (Pubitemid 34729044)
82. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002 ; 51: 2734-2741 (Pubitemid 34970926)
83. Shimono C, Manabe R, Yamada T, Fukuda S, Kawai J, Furutani Y, et al. Identification and characterization of nCLP2, a novel C1q family protein expressed in the central nervous system. J Biochem. 2010 ; 147: 565-579
84. Hirai H, Pang Z, Bao D, Miyazaki T, Li L, Miura E, et al. Cbln1 is essential for synaptic integrity and plasticity in the cerebellum. Nat Neurosci. 2005 ; 8: 1534-1541 (Pubitemid 41573668)
85. Bérubé NG, Swanson XH, Bertram MJ, Kittle JD, Didenko V, Baskin DS, et al. Cloning and characterization of CRF, a novel C1q-related factor, expressed in areas of the brain involved in motor function. Brain Res Mol Brain Res. 1999 ; 63: 233-240 (Pubitemid 29036973)
86. Hopfer U, Fukai N, Hopfer H, Wolf G, Joyce N, Li E, et al. Olsen3Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. FASEB J. 2005 ; 19: 1232-1244 (Pubitemid 41113720)
87. Hayward CP, Hassell JA, Denomme GA, Rachubinski RA, Brown C, Kelton JG. The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X. J Biol Chem. 1995 ; 270: 18246-18251
88. Hayward CP, Smith JW, Horsewood P, Warkentin TE, Kelton JG. p-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem. 1991 ; 266: 7114-7120 (Pubitemid 21906340)
89. Doliana R, Mongiat M, Bucciotti F, Giacomello E, Deutzmann R, Volpin D, et al. EMILIN, a component of the elastic fiber and a new member of the C1q/tumor necrosis factor superfamily of proteins. J Biol Chem. 1999 ; 274: 16773-16781
90. Doliana R, Bot S, Mungiguerra G, Canton A, Cilli SP, Colombatti A. Isolation and characterization of EMILIN-2, a new component of the growing EMILINs family and a member of the EMI domain-containing superfamily. J Biol Chem. 2001 ; 276: 12003-12011
91. Nakamura O, Wada Y, Namai F, Saito E, Araki K, Yamamoto A, Tsutsui S. A novel C1q family member with fucose-binding activity from surfperch, Neoditrema ransonnetii (Perciformes, Embiotocidae). Fish Shellfish Immunol. 2009 ; 27: 714-720
92. Schäffler A, Schölmerich J, Salzberger B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol. 2007 ; 28: 393-399 (Pubitemid 47385374)
93. Jeon JH, Kim KY, Kim JH, Baek A, Cho H, Lee YH, et al. A novel adipokine CTRP1 stimulates aldosterone production. FASEB J. 2008 ; 22: 1502-1511 (Pubitemid 351656790)
94. Akiyama H, Furukawa S, Wakisaka S, Maeda T. CTRP3/cartducin promotes proliferation and migration of endothelial cells. Mol Cell Biochem. 2007 ; 304: 243-248 (Pubitemid 47456872)
95. Wölfing B, Buechler C, Weigert J, Neumeier M, Aslanidis C, Schöelmerich J, Schäffler A. Effects of the new C1q/TNF-related protein (CTRP-3) "cartonectin" on the adipocytic secretion of adipokines. Obesity. 2008 ; 16: 1481-1486 (Pubitemid 351915097)
96. Maeda T, Wakisaka S. CTRP3/cartducin is induced by transforming growth factor-beta1 and promotes vascular smooth muscle cell proliferation. Cell Biol Int. 2010 ; 34: 261-266
97. Peterson JM, Wei Z, Wong GW. C1q/TNF-related protein-3 (CTRP3): a novel adipokine that regulates hepatic glucose output. J Biol Chem. 2010 ; 85: 39691-39701
98. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Ge G, Spooner E, Hug C, Gimeno R, Lodish HF. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J. 2009 ; 23: 241-258
99. Shapiro L, Scherer PE. The crystal structure of a C1q family protein suggests an evolutionary link to tumour necrosis factor. Current Biol. 1998 ; 8: 335-338 (Pubitemid 28159119)
100. Matsushita M, Matsushita A, Endo Y, Nakata M, Kojima N, Mizuochi T, et al. Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin. Proc. Natl. Acad. Sci. USA. 2004 ;: 10127-10131 (Pubitemid 38891206)
101. Païdassi H, Tacnet-Delorme P, Lunardi T, Arlaud GJ, Thielens NM, Frachet P. The lectin-like activity of human C1q and its implication in DNA and apoptotic cell recognition. FEBS Lett. 2008 ; 582: 3111-3116
102. Carland TM, Gerwick L. The C1q domain containing proteins: Where do they come from and what do they do?. Dev Comp Immunol. 2010 ; 34: 785-790
103. Yu Y, Huang H, Wang Y, Yu Y, Yuan S, Huang S, et al. A novel C1q family member of amphioxus was revealed to have a partial function of vertebrate C1q molecule. J Immunol. 2008 ; 181: 7024-7032
104. Albertí S, Marqués G, Hernández-Allés S, Rubires X, Tomás JM, Vivanco F, et al. Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36. Infect Immun. 1996 ; 64: 4719-4725 (Pubitemid 26357083)
105. Nonaka M, Smith SL. Complement system of bony and cartilaginous fish. Fish Shellfish Immunol. 2000 ; 10: 215-228
106. Boshra H, Li J, Sunyer JO. Recent advances on the complement system of teleost fish. Fish Shellfish Immunol. 2006 ; 20: 239-262 (Pubitemid 41033801)
107. Hu YL, Pan XM, Xiang LX, Shao JZ. Characterization of C1q in Teleosts: insight into the molecular and functional evolution of c1q family and classical pathway. J Biol Chem. 2010 ; 285: 28777-28786
108. Peake PW, Shen Y, Walther A, Charlesworth JA. Adiponectin binds C1q and activates the classical pathway of complement. Biochem Biophys Res Commun. 2008 ; 367: 560-565
109. Sørensen IJ, Nielsen EH, Andersen O, Danielsen B, Svehag SE. Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase. Scand J Immunol. 1996 ; 44: 401-407 (Pubitemid 26327024)
110. Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol. 2003 ; 33: 465-473 (Pubitemid 36267612)
111. Inforzato A, Peri G, Doni A, Garlanda C, Mantovani A, Bastone A, et al. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. Biochemistry. 2006 ; 45: 11540-11551 (Pubitemid 44454002)
112. Pisalyaput K, Tenner AJ. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms. J Neurochem. 2008 ; 104: 696-707
113. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, et al. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol. 2000 ; 164: 4178-4184 (Pubitemid 30215076)
114. Tacnet-Delorme P, Chevallier S, Arlaud GJ. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions. J Immunol. 2001 ; 167: 6374-6381 (Pubitemid 33081569)
115. Webster S, Glabe C, Rogers J. Multivalent binding of complement protein C1q to the amyloid β-peptide (Aβ) promotes the nucleation phase of Aβ aggregation. Biochem Biophys Res Commun. 1995 ; 217: 869-875
116. Païdassi H, Tacnet-Delorme P, Garlatti V, Darnault C, Ghebrehiwet B, Gaboriaud C, et al. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J Immunol. 2008 ; 180: 2329-2338
117. Oberkersch R, Attorresi AI, Calabrese GC. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy. Thromb Res. 2010 ; 125: 240-245
118. Castellano G, Woltman AM, Nauta AJ, Roos A, Trouw LA, Seelen MA, et al. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood. 2004 ; 103: 3813-3820 (Pubitemid 38596300)
119. Peerschke EI, Reid KB, Ghebrehiwet B. Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med. 1993 ; 178: 579-587 (Pubitemid 23218206)
120. Peerschke EI, Ghebrehiwet B. C1q augments platelet activation in response to aggregated Ig. J Immunol. 1997 ; 159: 5594-5598 (Pubitemid 127470089)
121. Baruah P, Dumitriu IE, Peri G, Russo V, Mantovani A, Manfredi AA, et al. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J Leukoc Biol. 2006 ; 80: 87-95 (Pubitemid 44835529)
122. Agrawal A, Singh PP, Bottazzi B, Garlanda C. Mantovani A Pattern recognition by pentraxins. Adv Exp Med Biol. 2009 ; 653: 98-116
123. Leigh LE, Ghebrehiwet B, Perera TP, Bird IN, Strong P, Kishore U, et al. C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. Biochem J. 1998 ; 330: 247-254
124. Goodman EB, Anderson DC, Tenner AJ. C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism. J Leukoc Biol. 1995 ; 58: 168-176
125. van den Berg RH, Faber-Krol MC, van Wetering S, Hiemstra PS, Daha MR. Inhibition of activation of the classical pathway of complement by human neutrophil defensins. Blood. 1998 ; 92: 3898-3903 (Pubitemid 28525216)
126. Groeneveld TW, Ramwadhdoebé TH, Trouw LA, van den Ham DL, van der Borden V, Drijfhout JW, et al. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation. Mol Immunol. 2007 ; 44: 3608-3614 (Pubitemid 46778752)
127. Bordin S, Ghebrehiwet B, Page RC. Participation of C1q and its receptor in adherence of human diploid fibroblast. J Immunol. 1990 ; 145: 2520-2526 (Pubitemid 20374573)
128. Oiki S, Okada Y. C1q induces chemotaxis and K+ conductance activation coupled to increased cytosolic Ca2+ in mouse fibroblasts. J Immunol. 1988 ; 141: 3177-3185
129. Ghebrehiwet B, Kew RR, Gruber BL, Marchese MJ, Peerschke EI, Reid KB. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. J Immunol. 1995 ; 155: 2614-2619
130. Kuna P, Iyer M, Peerschke EI, Kaplan AP, Reid KB, Ghebrehiwet B. Human C1q induces eosinophil migration. Clin Immunol Immunopathol. 1996 ; 81: 48-54 (Pubitemid 26338247)
131. Cutler AJ, Botto M, van Essen D, Rivi R, Davies KA, Gray D, et al. T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells. J Exp Med. 1998 ; 187: 1789-1797
132. Baruah P, Dumitriu IE, Malik TH, Cook HT, Dyson J, Scott D, et al. C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood. 2009 ; 113: 3485-3493
133. Ferry H, Potter PK, Crockford TL, Nijnik A, Ehrenstein MR, Walport MJ, et al. Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice. J Immunol. 2007 ; 178: 2916-2922 (Pubitemid 46333170)
134. Cutler AJ, Cornall RJ, Ferry H, Manderson AP, Botto M, Walport MJ. Intact B cell tolerance in the absence of the first component of the classical complement pathway. Eur J Immunol. 2001 ;: 2087-2093 (Pubitemid 32640725)
135. Hong Q, Sze CI, Lin SR, Lee MH, He RY, Schultz L, et al. Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells. PLoS One. 2009 ; 4: 57555-57555
136. Bhatia VK, Yun S, Leung V, Grimsditch DC, Benson GM, Botto MB, et al. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol. 2007 ; 170: 416-426 (Pubitemid 47339218)